Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cesar: naltrexone vs fluoxetine for compulsive sexual behavior disorder
2019-004255-36Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in hypersexuality comparing Naltrexone with Fluoxetine (2 arms). Primary endpoint: Change in CAS questionnaire score. Started Jun 2020; status: completed.
02
Drugs
naltrexonefluoxetine
03
Conditions
hypersexuality
Beyond the preview
Go deeper on 2019-004255-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004255-36.